Skip to main content
. 2019 Dec 16;98(50):e18355. doi: 10.1097/MD.0000000000018355

Table 2.

Subgroup analyses for evaluating the effect of hyperthermic intraperitoneal chemotherapy on the survival of patients with primary disease.

3.2.